PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 126 filers reported holding PLIANT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $877 | -0.9% | 50,575 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $885 | +47.7% | 48,850 | +117.1% | 0.00% | 0.0% |
| Q1 2023 | $599 | +52.4% | 22,500 | +10.6% | 0.00% | 0.0% |
| Q4 2022 | $393 | -99.9% | 20,350 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | +84.2% | 19,500 | -29.4% | 0.00% | – |
| Q2 2022 | $221,000 | -28.0% | 27,613 | -36.9% | 0.00% | – |
| Q1 2022 | $307,000 | -27.1% | 43,771 | +40.5% | 0.00% | – |
| Q4 2021 | $421,000 | +52.5% | 31,149 | +90.5% | 0.00% | – |
| Q3 2021 | $276,000 | -56.3% | 16,353 | -24.6% | 0.00% | -100.0% |
| Q2 2021 | $632,000 | -14.0% | 21,691 | +16.0% | 0.00% | 0.0% |
| Q1 2021 | $735,000 | +240.3% | 18,700 | +96.8% | 0.00% | – |
| Q4 2020 | $216,000 | +300.0% | 9,500 | +295.8% | 0.00% | – |
| Q3 2020 | $54,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |